Use access key #2 to skip to page content.
$29.93 -1.82 (-5.73%)
10/10/2008 4:00 PM

Pharmaceutical Product Development, Inc. (PPDI)

CAPS Rating:
*****

The Company is a global contract research organization providing drug discovery and development services, post-approval expertise and compound partnering programs.

View All Commentary (PPDI)

Recs

1

Avatar dexion10 (< 20) Submitted: 10/25/07 10:32 AM : Underperform Start Price: $41.09 PPDI Score: -14.53

The biz model of developing drugs internally will prove to be a drag on this company - the drugs they buy are drugs that other pharmas didn't want... for example their Statin drug and diabetes candidates are also rans.... nothing exceptional.

Worse their statin will hit the market after Lipitor is a generic drug... DUMB.

Finally the valuation at $40 is priced perfectly - I don't see outperformance in PPDI's near-term future. I see the market outpacing this one.

Report this Post Replies: 0 | Reply

Featured Broker Partners